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Abstract 
Apoptosis is a selective process for deleting cells in 
various biological systems and plays an essential 
role in the development and maintenance of tissue 
homeostasis in multicellular organisms and 
inappropriate regulation of apoptosis is believed to 
be the cause of many human diseases, including 
cancer (Thompson, 1995). 
Apoptosis relies on cysteine proteases called 
caspases (CASPs). Caspases are synthesized as 
proforms and become activated by cleavage at 
aspartate residues. Initiator caspases (1, 2, 4, 5, 8, 9, 
10, 11, and 12) integrate molecular signals and 
activate the downstream effector caspases (3, 6, 7, 
and 14). Because caspases cleave and activate each 
other, the protease cascade amplifies, ensuring 
proper apoptotic cell death. In addition, caspases 
cleave numerous substrates, such as nuclear lamins, 
inhibitors of DNase, and cytoskeletal proteins, 
resulting in the typical morphological alterations of 
apoptosis (Cohen, 1997; Denault and Salvesen, 
2002; Boatright and Salvesen, 2003).  
Caspase-7 is highly related to caspase-3, and these 
two caspases are activated by both death receptor- 
and mitochondria-induced apoptosis (Soung et al., 
2003).  
Besides its activation during apoptosis, proteolytic 
maturation of caspase-7 has also been observed 
under inflammatory conditions (Lamkanfi and 
Kanneganti, 2010). 
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Other names: CASP-7, CMH-1, ICE-LAP3, 
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HGNC (Hugo): CASP7 
Location: 10q25.3 
Local order: Plus strand. 
 
CASP7 transcript variants. Coding exons are marked by blue blocks, and non-coding exons, 5- and 3-UTRs are marked by 
white blocks. 
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Structure of procaspase-7. Numbers below the stick represents the approximate MWs of the resulting subunits and pro-
regions. The proenzymes are cleaved at specific Asp residues (Dn, where n is the position in the protein). 
 
 
DNA/RNA 
Description 
CASP7 gene contains 8 exons and spans 51.748 Kb 
of genomic DNA. 
Transcription 
CASP7 gene has 9 transcripts (splice variants): 
- CASP7-201: 2694 bp (8 exons; 7 coding exons) 
- CASP7-005: 2659 bp (8 exons; 6 coding exons) 
- CASP7-002: 2421 bp (8 exons; 6 coding exons) 
- CASP7-003: 2380 bp (8 exons; 7 coding exons) 
- CASP7-001: 2377 bp (7 exons; 6 coding exons) 
- CASP7-202: 1148 bp (6 exons; 6 coding exons) 
- CASP7-004: 834 bp (6 exons; 5 coding exons) 
- CASP7-007: 607 bp (3 exons; 0 coding exons) 
- CASP7-008: 799 bp (5 exons; 0 coding exons). 
Pseudogene 
Not identified. 
Protein 
Description 
Caspase-7 is an effector caspase and plays an 
central role in the execution phase of the apoptosis. 
Expression 
Caspase-7 is widely expressed in human tissues. 
Highly expressed in lung, skeletal muscle, liver, 
kidney, spleen and heart, and moderately in testis. 
Localisation 
Mainly in the cytoplasm, but also observed in the 
nucleus. 
Function 
Effector caspases are responsible for initiating the 
hallmarks of the degradation phase of apoptosis, 
including DNA fragmentation, cell shrinkage and 
membrane blebbing.  
Besides its activation during apoptosis, proteolytic 
maturation of caspase-7 has also been observed 
under inflammatory conditions. 
Homology 
CASP7 (P. troglodytes, M. mulatta, C. lupus, B. 
taurus, G. gallus), Casp7 (M. musculus, R. 
norvegicus), casp7 (X. tropicalis, D. rerio), Ice (D. 
melanogaster), Dcp-1 (D. melanogaster), CASPS7 
(A. gambiae). 
 
Mutations 
Soung et al. (2003) detected CASP7 mutations in 2 
of 98 colon carcinomas (2%), 1 of 50 esophageal 
carcinomas (2%), and 1 of 33 head/neck 
carcinomas (3%).  
Expression of the tumor-derived CASP7 mutants in 
293T cells showed that apoptosis was reduced 
compared to the wild-type caspase-7, suggesting 
that inactivating mutations of CASP7 might 
contribute to the pathogenesis of some human solid 
cancers. 
Genetic polymorphisms in the CASP7 gene may 
affect cancer risk through altering expression levels 
and functions of this gene. Several polymorphisms 
have been associated with susceptibility of cancer 
development, as will be discussed later (Yan et al., 
2013). 
A detailed list of genetic variations could be found 
at: Ensembl. 
Implicated in 
Lung cancer 
Note 
Lee et al. (2009) showed that the CASP7 rs2227310 
g.C>G polymorphism was associated with the risk 
of lung cancer.  
Yoo et al. (2009) also demonstrated that the CASP7 
rs2227310 polymorphism may affect survival in 
early-stage non-small cell lung cancer (NSCLC), 
suggesting that the analysis of this polymorphism 
can help identify patients at high risk for a poor 
disease outcome.  
Qian et al. (2012) also provided evidence that 
genetic variations of CASP7 may modulate overall 
survival and progression-free survival of patients 
with advanced NSCLC treated with platinum-based 
chemotherapy. 
Esophageal cancer 
Note 
Liu et al. (2010) described that polymorphisms in 
CASP7 gene was associated with increased risk of 
esophageal cancer. 
Childhood leukemia 
Note 
Park et al. (2012) suggested that three SNPs in 
CASP7 acts as a strong apoptosis signal that block 
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or delay the apoptosis of childhood leukemia cancer 
cells. 
Colorectal cancer 
Note 
Palmerini et al. (2001) described a loss of caspase-7 
in 84% of colon cancers, suggesting that caspase-7 
deficiency might be used as a new 
immunohistochemical marker of colonic neoplasia.  
Chae et al. (2011) reported that CASP7 rs2227310 
polymorphism may be useful marker to predict the 
prognosis of patients with surgically resected 
colorectal cancer. 
Gastric cancer 
Note 
Yoo et al. (2004) observed loss of capase-2, capase-
6 and capase-7 expression in gastric cancers 
irrespective of depth of invasion and histological 
subtypes suggesting a role in the development of 
gastric cancers. 
Endometrial cancer 
Note 
The AA genotype of rs11196445b, the CC 
genotype of rs3124740, and the GG genotype of 
rs10787498 in the CASP7 gene were associated 
with increased risk compared with homozygotes of 
the major alleles, suggesting that genetic variants in 
CASP7 may play a role in endometrial cancer 
susceptibility in a Chinese population (Xu et al., 
2009). 
Renal carcinoma 
Note 
Vilella-Arias et al. (2013) reported loss of CASP7 
protein expression in renal cell carcinoma clear cell 
subtype (ccRCC) and this loss was associated with 
the agressiveness of ccRCC, suggesting the 
potential use of CASP7 as a prognostic marker. 
Oral squamous cell carcinoma 
Note 
Coutinho-Camillo et al. (2011) reported that high 
expression level of CASP7 protein was associated 
with poor prognosis in oral squamous cell 
carcinoma (OSCC) patients. 
Alzheimer's disease 
Note 
Elevated mRNA levels of caspases-7 and 8 
measured by a quantitative PCR method were 
observed in the Alzheimer's disease (AD) temporal 
neocortex as compared to the control brains, 
suggesting that the transcriptional activation of key 
components of the apoptotic cascade correlates with 
accumulation of Abeta42.  
Thus, a principal caspase pathway from caspase-8 
to caspase-3 and/or 7 may contribute to neuron loss 
in AD brain (Matsui et al., 2006). 
Huntington's disease 
Note 
Hermel et al. (2004) reported that caspase-7 
immunoreactivity in post-mortem tissue from 
Huntington's disease (HD) patients is dramatically 
enhanced in the medium spiny neurons of the 
caudate nucleus and neurons in the putamen when 
compared to age-matched controls.  
Caspase-7 is able to bind full-length huntingtin 
(Htt), accelerating the production of Htt fragments 
and resulting in the eventual induction of apoptosis 
both in the neuronal processes and somata. 
Rheumatoid arthritis 
Note 
CASP-7 gene is associated with the susceptibility to 
rheumatoid arthritis (RA). Genotyping of three 
single nucleotide polymorphisms (SNPs) of the 
CASP7 gene: rs11593766 (G/T), rs2227310 (C/G) 
and rs2227309 (G/A) revealed that rs2227309 SNP 
was found to be associated with susceptibility to 
RA.  
Frequency of the G allele was significantly higher 
among RA patients and a higher frequency of GG 
homozygous individuals was found in the RA 
patient group (Garcia-Lozano et al., 2007). 
Teixeira et al. (2008) found that CASP7 rs2227309 
SNP was not associated with RA in a European 
Caucasian population. Nevertheless, CASP7 
isoforms alpha and beta could be involved in the 
apoptosis process in RA. 
Insulin-dependent diabetes mellitus 
Note 
Babu et al. (2003) studied 18 SNPs in CASP7 and 
reported that 1 (SNP144692) differed significantly 
in frequency in the haplotypes found in affected 
individuals compared to control Bedouin Arab 
family haplotypes. This same SNP showed 
evidence of association with diabetes in a subset of 
patients (DR3/DR4*0302) from Human Biological 
Data Interchange (HBDI) families, although these 
results are in conflict with other studies. 
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